LIVEPERSON INC (LPSN)

US5381461012 - Common Stock

0.85  0 (0%)

After market: 0.86 +0.01 (+1.18%)

Fundamental Rating

1

Overall LPSN gets a fundamental rating of 1 out of 10. We evaluated LPSN against 280 industry peers in the Software industry. Both the profitability and financial health of LPSN have multiple concerns. LPSN does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
LPSN had a negative operating cash flow in the past year.
In the past 5 years LPSN always reported negative net income.
In multiple years LPSN reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of LPSN (-9.06%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -136.52%, LPSN is doing worse than 80.65% of the companies in the same industry.
Industry RankSector Rank
ROA -9.06%
ROE -136.52%
ROIC N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 66.52%, LPSN perfoms like the industry average, outperforming 47.67% of the companies in the same industry.
LPSN's Gross Margin has declined in the last couple of years.
LPSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%

More info and screens

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LPSN has been increased compared to 1 year ago.
Compared to 5 years ago, LPSN has more shares outstanding
Compared to 1 year ago, LPSN has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.55, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
LPSN has a Altman-Z score of -1.55. This is in the lower half of the industry: LPSN underperforms 78.14% of its industry peers.
A Debt/Equity ratio of 10.24 is on the high side and indicates that LPSN has dependencies on debt financing.
The Debt to Equity ratio of LPSN (10.24) is worse than 87.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF N/A
Altman-Z -1.55
ROIC/WACCN/A
WACC1.82%

2.3 Liquidity

LPSN has a Current Ratio of 1.27. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, LPSN is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
LPSN has a Quick Ratio of 1.27. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
LPSN has a worse Quick ratio (1.27) than 62.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.28% over the past year.
The Revenue for LPSN has decreased by -21.97% in the past year. This is quite bad
LPSN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.98% yearly.
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Sales Q2Q%-26.73%

3.2 Future

LPSN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.74% yearly.
The Revenue is expected to decrease by -13.31% on average over the next years. This is quite bad
EPS Next Y55.83%
EPS Next 2Y9.22%
EPS Next 3Y-3.74%
EPS Next 5YN/A
Revenue Next Year-23.25%
Revenue Next 2Y-19.77%
Revenue Next 3Y-13.31%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LPSN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as LPSN's earnings are expected to decrease with -3.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.22%
EPS Next 3Y-3.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEPERSON INC

NASDAQ:LPSN (12/24/2024, 3:17:15 PM)

After market: 0.86 +0.01 (+1.18%)

0.85

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners37.98%
Inst Owner Change-24.3%
Ins Owners5.61%
Ins Owner Change19.43%
Market Cap77.22M
Analysts49.09
Price Target0.98 (15.29%)
Short Float %10.18%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)145.3%
Min EPS beat(2)-41.32%
Max EPS beat(2)331.92%
EPS beat(4)1
Avg EPS beat(4)53.07%
Min EPS beat(4)-52.62%
Max EPS beat(4)331.92%
EPS beat(8)3
Avg EPS beat(8)0.49%
EPS beat(12)6
Avg EPS beat(12)17.18%
EPS beat(16)10
Avg EPS beat(16)101.92%
Revenue beat(2)2
Avg Revenue beat(2)1.78%
Min Revenue beat(2)1.22%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)1.62%
Min Revenue beat(4)-0.57%
Max Revenue beat(4)3.47%
Revenue beat(8)4
Avg Revenue beat(8)-0.18%
Revenue beat(12)6
Avg Revenue beat(12)-0.23%
Revenue beat(16)9
Avg Revenue beat(16)0.15%
PT rev (1m)-12.5%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.46%
EPS NY rev (1m)-66.67%
EPS NY rev (3m)-54.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.9%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)-1.03
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS3.68
BVpS0.51
TBVpS-3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.06%
ROE -136.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.52%
FCFM N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.14%
Cap/Sales 9.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -1.55
F-Score4
WACC1.82%
ROIC/WACCN/A
Cap/Depr(3y)100%
Cap/Depr(5y)143.23%
Cap/Sales(3y)9.45%
Cap/Sales(5y)11.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y55.83%
EPS Next 2Y9.22%
EPS Next 3Y-3.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Sales Q2Q%-26.73%
Revenue Next Year-23.25%
Revenue Next 2Y-19.77%
Revenue Next 3Y-13.31%
Revenue Next 5YN/A
EBIT growth 1Y12.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year434.18%
EBIT Next 3Y81.7%
EBIT Next 5YN/A
FCF growth 1Y76.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.31%
OCF growth 3YN/A
OCF growth 5YN/A